ICON plc’s ICLR focus on Patient Access & Engagement strategy and favorable CRO industry trends are major tailwinds. Strategic partnerships are an added plus. The stock carries a Zacks Rank #2 (Buy) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback